This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raines, M A
Right arrow Articles by Kung, H J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raines, M A
Right arrow Articles by Kung, H J

 Previous Article  |  Next Article 

J Virol. 1988 July; 62(7): 2444-2452

Molecular characterization of three erbB transducing viruses generated during avian leukosis virus-induced erythroleukemia: extensive internal deletion near the kinase domain activates the fibrosarcoma- and hemangioma-inducing potentials of erbB.

M A Raines, N J Maihle, C Moscovici, M G Moscovici and H J Kung

Department of Molecular Biology and Microbiology, Case Western Reserve University, School of Medicine, Cleveland, Ohio 44106.

ABSTRACT

Three new erbB transducing viruses generated during avian leukosis virus-induced erythroblastosis have been cloned and sequenced, and their transforming abilities have been analyzed. Provirus 9134 E1 expresses an amino-terminally truncated erbB product that is analogous to the proviral insertionally activated c-erbB gag-erbB fusion product. This virus efficiently induces erythroblastosis, but does not transform fibroblasts in vitro or induce sarcomas in vivo. In contrast, virus 9134 S3 expresses an erbB product identical to the erbB product of 9134 E1, with the exception of a large internal deletion located between the kinase domain and the putative autophosphorylation site, P1. Interestingly, this virus is no longer capable of inducing erythroblastosis, but can induce both fibrosarcomas and hemangiomas in vivo. Provirus 9134 F3 has sustained an approximately 23-amino-acid carboxy-terminal truncation and is capable of inducing both erythroblastosis and sarcomagenesis. This virus expresses an erbB product with the shortest carboxy-terminal truncation sufficient to reveal the sarcomagenic potential of this protein. The distinct transforming properties of these viruses indicate that different structural domains of the erbB product confer distinct disease specificities.

J Virol. 1988 July; 62(7): 2444-2452




This article has been cited by other articles:

  • Boerner, J., McManus, M., Martin, G., Maihle, N. (2000). Ras-independent oncogenic transformation by an EGF-receptor mutant. J. Cell Sci. 113: 935-942 [Abstract]  
  • McManus, M. J., Lingle, W. L., Salisbury, J. L., Maihle, N. J. (1997). A transformation-associated complex involving tyrosine kinase signal adapter proteins and caldesmon links v-ErbB signaling to actin stress fiber disassembly. Proc. Natl. Acad. Sci. USA 94: 11351-11356 [Abstract] [Full Text]  
  • Boerner, J. L., Danielsen, A., McManus, M. J., Maihle, N. J. (2001). Activation of Rho Is Required for Ligand-independent Oncogenic Signaling by a Mutant Epidermal Growth Factor Receptor. J. Biol. Chem. 276: 3691-3695 [Abstract] [Full Text]  
  • McManus, M. J., Boerner, J. L., Danielsen, A. J., Wang, Z., Matsumura, F., Maihle, N. J. (2000). An Oncogenic Epidermal Growth Factor Receptor Signals via a p21-activated Kinase-Caldesmon-Myosin Phosphotyrosine Complex. J. Biol. Chem. 275: 35328-35334 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»